1. Search Result
Search Result
Results for "

BMI

" in MedChemExpress (MCE) Product Catalog:

22

Inhibitors & Agonists

2

Natural
Products

1

Recombinant Proteins

5

Antibodies

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-139514

    E1/E2/E3 Enzyme Cancer
    RB-3, a polycomb repressive complex 1 (PRC1) inhibitor, binds to RING1B-BMI1f, with a Kd of 2.8 μM .
    RB-3
  • HY-15888
    PTC-209
    Maximum Cited Publications
    16 Publications Verification

    BMI1 Autophagy Cancer
    PTC-209 is a specific BMI-1 inhibitor with an IC50 of 0.5 μM in HEK293T cell line. PTC-209 irreversibly impairs colorectal cancer-initiating cells (CICs). PTC-209 shows potent anti-myeloma activity and impairs the tumor microenvironment .
    PTC-209
  • HY-112041
    Unesbulin
    3 Publications Verification

    PTC596

    BMI1 Apoptosis Cancer
    Unesbulin (PTC596) is an orally active and selective B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) inhibitor. Unesbulin downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia (AML) cells. Unesbulin has anti-leukemic activity .
    Unesbulin
  • HY-W010937

    BMIM-TFSI; BMI-TFSI

    HIV HIV Integrase Infection
    1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide (BMIM-TFSI; BMI-TFSI) is an HIV-1 integrase inhibitor. 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide weakly inhibits recombinant HIV-1 integrase 3'-processing or strand transfer activity. 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide can be used for the research of HIV-1 .
    1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide
  • HY-103696
    PTC-028
    2 Publications Verification

    BMI1 Apoptosis Cancer
    PTC-028 is an orally bioavailable inhibitor of stem cell factor BMI-1 in ovarian cancer. PTC-028 selectively inhibits cancer cells whereas normal cells remain unaffected. PTC-028 downregulates BMI-1, inducing caspase-mediated apoptosis .
    PTC-028
  • HY-160924

    PROTACs BMI1 E1/E2/E3 Enzyme Histone Methyltransferase Cancer
    MS147 is a VHL-based PROTAC degrader of BMI1 and RING1B (polycomb repressive complex 1 core components). MS147 directly binds EED and VHL E3 ligase, recruiting the ligase to the EED-BMI1/RING1B complex to induce time-dependent, ubiquitination-mediated degradation of BMI1 and RING1B. MS147 reduces histone H2A Lys119 mono-ubiquitination without altering histone H3 Lys27 tri-methylation and inhibits cancer cells proliferation. MS147 can be used for the research of cancer, such as chronic myelogenous leukemia and b-cell lymphoma . (Pink: BMI1/RING1B ligand (HY-183634); Blue: VHL ligand (HY-125845); Black: linker)
    MS147
  • HY-170823

    E1/E2/E3 Enzyme Cancer
    PRC1-IN-1 is a PRC1 complex inhibitor. PRC1-IN-1 binds to both RING1A and RING1B proteins, and inhibits the activities of RING1B-BMI1 and RING1B-PCGF1. PRC1-IN-1 effectively inhibits H2AK119 ubiquitination and induces cell differentiation in leukemia cells. PRC1-IN-1 can be used for the research of leukemia .
    PRC1-IN-1
  • HY-158239

    PROTACs E1/E2/E3 Enzyme Cancer
    MS181 (compound 1) is a potent cereblon (CRBN)-recruiting and EED-binding polycomb repressive complex 1 (PRC1) PROTAC degrader. MS181 decreases the expression of EED, EZH2, SUZ12, BMI1 and RING1B. MS181 shows antiproliferative activity (Strtucture Note: Red, EED binder (HY-158771); Blue, CRBN ligand (HY-41547); Black, Linker HY-131717) .
    MS181
  • HY-15888A
    PTC-209 hydrobromide
    Maximum Cited Publications
    16 Publications Verification

    BMI1 Autophagy Cancer
    PTC-209 hydrobromide is a specific BMI-1 inhibitor with an IC50 of 0.5 μM in HEK293T cell line. PTC-209 hydrobromide irreversibly impairs colorectal cancer-initiating cells (CICs). PTC-209 hydrobromide shows potent anti-myeloma activity and impairs the tumor microenvironment .
    PTC-209 hydrobromide
  • HY-123369

    CDK Apoptosis Cancer
    BMI-1026 is a cyclin-dependent kinase 1 (Cdk1) inhibitor with IC50 of 2.3 nM. BMI-1026 induces apoptosis by arresting the G2-M phase .
    BMI-1026
  • HY-143655

    BMI1 Autophagy Cancer
    QW24 exerts potent anti-tumor activity by down-regulating BMI-1 and is used as an effective therapeutic agent for clinical colorectal cancer research.
    QW24
  • HY-116126

    Aminopeptidase Cancer
    Leuhistin is an AP-M (aminopeptidase-M) inhibitor. AP-M is an inactivating enzyme of bioactive peptides in cerebral membranes. Leuhistin can be produced by Bacillus laterosporus BMI156-14F1 .
    Leuhistin
  • HY-164463

    Estrogen Receptor/ERR Apoptosis Cancer
    BMI-135 is a selective estrogen mimic, that exhibits agonist activity for estrogen receptor. BMI-135 induces rapid endoplasmic reticulum stress response (UPR) and apoptosis in breast cancer cells .
    BMI-135
  • HY-146343

    Fluorescent Dye γ-Glutamyl Transferase (GGT) Inflammation/Immunology Cancer
    BMI-Glu is a selective γ-glutamyl transpeptidase (GGT) fluorescent probe with a Km of 69.63 µM. BMI-Glu has high sensitivity, good water solubility and biocompatibility .
    BMI-Glu
  • HY-RS01532

    Small Interfering RNA (siRNA) Others

    BMI1 Human Pre-designed siRNA Set A contains three designed siRNAs for BMI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    BMI1 Human Pre-designed siRNA Set A
    BMI1 Human Pre-designed siRNA Set A
  • HY-RS18603

    Small Interfering RNA (siRNA) Others

    Bmi1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bmi1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Bmi1 Mouse Pre-designed siRNA Set A
    Bmi1 Mouse Pre-designed siRNA Set A
  • HY-143658

    BMI1 Autophagy Cancer
    SH498, a novel Bmi-1-mediated antitumor agent, shows potent antiproliferative activity.
    SH498
  • HY-172617

    BMI1 Microtubule/Tubulin Apoptosis Cancer
    APD-94 is a dual inhibitor targeting tubulin and Bmi-1. APD-94 interfers tubulin normal polymerization. APD-94 suppresses the expression of Bmi-1. APD-94 causes cell cycle arrest at the G2/M phase in cancer cells and induces apoptosis, thus inhibiting cancer cell proliferation. APD-94 represses the growth of HT29 cell xenografts in NOD/SCID mice. APD-94 can be used for colorectal cancer study .
    APD-94
  • HY-N0992

    BMI1 Apoptosis Cancer
    1,6,7-Trihydroxyxanthone is a potent anticancer agent. 1,6,7-Trihydroxyxanthone inhibits cell proliferation and induces cell Apoptosis. 1,6,7-Trihydroxyxanthone decreases Bmi-1 expressio and increases the protein levels expression of P14, P16 .
    1,6,7-Trihydroxyxanthone
  • HY-183634

    Ligands for Target Protein for PROTAC BMI1 Others
    BMI1/RING1B ligand-1 is a BMI1/RING1B ligand. BMI1/RING1B ligand-1 can be used to synthesize PROTAC S147 (HY-160924).
    BMI1/RING1B ligand-1
  • HY-RS25088

    Small Interfering RNA (siRNA) Others

    Bmi1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bmi1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Bmi1 Rat Pre-designed siRNA Set A
    Bmi1 Rat Pre-designed siRNA Set A
  • HY-103696R

    BMI1 Reference Standards Apoptosis Cancer
    PTC-028 (Standard) is the analytical standard of PTC-028 (HY-103696). This product is intended for research and analytical applications. PTC-028 is an orally bioavailable inhibitor of stem cell factor BMI-1 in ovarian cancer. PTC-028 selectively inhibits cancer cells whereas normal cells remain unaffected. PTC-028 downregulates BMI-1, inducing caspase-mediated apoptosis .
    PTC-028 (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: